AgelessRx vs Care Bare Rx
One of these publishes the concentration, the vial sizes and the milligrams per injection; the other publishes a price and stops.
Updated
AgelessRx
Editorial
$149/mo
Prints the introductory month and the rate that follows it in the same block, and publishes the concentration and vial totals — so the price can actually be checked against a dose.
Pick it for: Working out milligrams per injection, and prepaying a quarter to get the advertised rate
Care Bare Rx
Editorial
$199/mo
A telehealth brand that puts NAD⁺ on the same footing as everything else it sells, with the price on the page before you hand over an email.
Pick it for: A single month-to-month number, a one-day provider review, and FSA or HSA payment
Our verdict
AgelessRx states that its NAD⁺ is 200 mg/ml, that a 2.5 ml vial holds 500 mg and a 5 ml vial 1,000 mg, and that 0.1 ml is 20 mg, 0.25 ml is 50 mg and 0.5 ml is 100 mg — enough to work out what a week of injections actually delivers. Care Bare Rx publishes $199 and leaves the quantity blank. The catch sits on the AgelessRx side and it is not small: the $79 in its headline is an introductory month on a three-month plan billed in full, the standing rate is $149, and the plain month-to-month plan it advertises has no published price at all. So this is $199 you can rely on against $149 you have to read a footnote to understand, with the milligrams available only on the second one. If you will prepay a quarter, AgelessRx is both cheaper and far more informative; if you will not, ask what a single month costs before you assume $149 applies to you.
What actually separates them
AgelessRx and Care Bare Rx state different things about published price, states a milligram dose and states legitscript certification. Everything else they publish, they publish the same way.
Care Bare Rx costs $50 more than AgelessRx — 34% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $1,788 at AgelessRx against $2,388 at Care Bare Rx — a difference of $600.
| AgelessRx | Care Bare Rx | |
|---|---|---|
| Published price | $149/mo | $199/mo |
| States a milligram dose | Yes | No |
| States LegitScript certification | Yes | Not stated |
Where they differ on what they tell you
Price is the easy comparison and often the least useful one. These are the places where one of these two answers a question the other leaves open.
- Milligrams
- AgelessRx publishes how much NAD⁺ you get; Care Bare Rx does not, so $199 at Care Bare Rx buys a quantity nobody has told you.
- Certification
- AgelessRx states LegitScript certification and Care Bare Rx does not — a review of how a business operates rather than of what is in the vial, so it separates AgelessRx from Care Bare Rx on process and not on product.
- The advertised price
- AgelessRx leads with quarter paid up front — $79 against $149, while care Bare Rx advertises the rate it goes on charging.
- Routes offered
- AgelessRx also sells a nasal spray and a patch, while Care Bare Rx offers only a subcutaneous injection — which matters if you change your mind about the format later.
- The gap, over a year
- On the injection both sell, AgelessRx at $149 against Care Bare Rx at $199 is 34% — about $600 a year, if you stay on either for twelve months and neither price moves.
What neither of them tells you
A comparison that only reports differences implies everything else is settled. Here it is not.
- Both sell a compounded drug and neither names the pharmacy that compounds it.
- Neither states whether any bloodwork is included, or what it would cost.
- Neither publishes which states it can ship to.
Before you choose either
Only one of these two publishes a milligram dose, which makes a straight price comparison impossible: you can tell what each costs, but only one tells you what you get. Ask the other what dose its price buys before you commit, then put both numbers through our cost-per-milligram calculator. A seller that will not answer that question has told you something.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.